Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 426, doi. 10.1002/cpdd.689
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 4
Results: 16
1
2
Effect of Food on the Pharmacokinetics of a Combination of Olanzapine and Samidorphan.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 503, doi. 10.1002/cpdd.688
- By:
- Publication type:
- Article
3
A Cocktail Interaction Study Evaluating the Drug‐Drug Interaction Potential of the Perpetrator Drug ASP8477 at Multiple Ascending Dose Levels.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 529, doi. 10.1002/cpdd.660
- By:
- Publication type:
- Article
4
Effects of Rifamycin Coadministration on Bedaquiline Desmethylation in Healthy Adult Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 436, doi. 10.1002/cpdd.639
- By:
- Publication type:
- Article
5
Toward Dynamic Prescribing Information: Codevelopment of Companion Model‐Informed Precision Dosing Tools in Drug Development.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 418, doi. 10.1002/cpdd.638
- By:
- Publication type:
- Article
6
Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open‐Label Randomized Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 549, doi. 10.1002/cpdd.634
- By:
- Publication type:
- Article
7
Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single‐Tablet Regimen.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 541, doi. 10.1002/cpdd.632
- By:
- Publication type:
- Article
8
Bioequivalence of the Once‐Daily Single‐Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 480, doi. 10.1002/cpdd.628
- By:
- Publication type:
- Article
9
Pharmacokinetics of Tenofovir Alafenamide, Tenofovir, and Emtricitabine Following Administration of Coformulated Emtricitabine/Tenofovir Alafenamide in Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 511, doi. 10.1002/cpdd.623
- By:
- Publication type:
- Article
10
Effect of a High‐Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor Cabotegravir.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 443, doi. 10.1002/cpdd.620
- By:
- Publication type:
- Article
11
Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor‐α and Interleukin 17A, ABBV‐257, in Healthy Volunteers and Patients With Rheumatoid Arthritis.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 492, doi. 10.1002/cpdd.611
- By:
- Publication type:
- Article
12
Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 521, doi. 10.1002/cpdd.608
- By:
- Publication type:
- Article
13
A Study to Assess the Proarrhythmic Potential of Mirtazapine Using Concentration‐QTc (C‐QTc) Analysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 449, doi. 10.1002/cpdd.605
- By:
- Publication type:
- Article
14
Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 459, doi. 10.1002/cpdd.601
- By:
- Publication type:
- Article
15
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 413, doi. 10.1002/cpdd.592
- Publication type:
- Article
16
Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 467, doi. 10.1002/cpdd.579
- By:
- Publication type:
- Article